MPOX (formerly known as monkeypox)

Note: Consistent with the World Health Organization announcement on November 28, 2022, PHO will now refer to human monkeypox disease as MPOX and monkeypox virus as MPOX virus. However, to remain consistent with ICTV nomenclature, PHO laboratory tests for MPOX virus will continue to be referred to as monkeypox virus tests.

MPOX is a viral illness that causes a rash or lesions on a person’s body that can be in a single location (e.g., genital area, mouth) or all over the body. Other symptoms that can happen before or after the rash include fever/chills, fatigue, swollen lymph nodes, headache, muscle aches, and sore throat. During the 2022 global outbreak, MPOX virus has most commonly spread to people through direct close contact with an infected person including intimate or sexual contact.

If you are a healthcare provider looking for current Monkeypox guidance, including case and contact management, and vaccine and antiviral guidance, please visit the Ministry of Health’s MPOX Virus webpage.

If you are a healthcare provider looking for current Monkeypox guidance, including case and contact management, and vaccine and antiviral guidance, please visit the Ministry of Health’s Monkeypox Virus webpage.

Featured

 

Chat icon

Contact the Department

Enteric, Zoonotic and Vector-Borne Diseases

ezvbd@oahpp.ca

contact lab

Contact Laboratory Customer Service

Laboratory Services

customerservicecentre@oahpp.ca

Updated 28 Oct 2022